Last updated on June 2019

Clinical Trial to Evaluate the Efficacy Safety and Tolerability of RO7239361 in Ambulatory Boys With Duchenne Muscular Dystrophy

Brief description of study

This is a multi-center, randomized, double-blind, placebo-controlled study to assess the efficacy, safety and tolerability of two different weekly doses of RO7239361 in ambulatory boys with Duchenne Muscular Dystrophy (DMD).

Clinical Study Identifier: NCT03039686

Find a site near you

Start Over

Stanford University

Palo Alto, CA United States
  Connect »

University of Florida

Gainesville, FL United States
  Connect »

Nemours Children's Hospital

Orlando, FL United States
  Connect »

Rare Disease Research, LLC

Atlanta, GA United States
  Connect »

University of Iowa

Iowa City, IA United States
  Connect »

Kennedy Krieger Institute

Baltimore, MD United States
  Connect »

Saint Louis Children's Hospital

Saint Louis, MO United States
  Connect »

Las Vegas Clinic

Las Vegas, NV United States
  Connect »

Seattle Children's Hospital

Seattle, WA United States
  Connect »

Instituto centenario

Buenos Aires, Argentina
  Connect »

UZ Gent

Gent, Belgium
  Connect »

Hospital Sant Joan De Deu

Esplugues De Llobregas, Spain
  Connect »

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.